カテゴリ： visiongain, 世界, 医療/バイオ

組換えタンパク質のグローバル市場2023-2033：サイトカイン・成長因子、抗体、酵素、その他

■ 英語タイトル：Recombinant Proteins Market Report 2023-2033 : Forecasts by Products & Services (Cytokines & Growth Factors (Interferons (IFNs), Interleukins (ILS), Others), Antibodies, Enzymes (Kinases Enzymes, Metabolic Enzymes, Others), Recombinant Regulatory Protein, Hormones, Virus Antigens, Immune Checkpoint Proteins, Others)), Services), by Application (Biopharmaceutical Production (Biologics, Vaccines, Cell & Gene Therapy, Others), Drug Discovery & Development, Research, Diagnostics, Others)), by Host Cell (Mammalian Systems, Bacterial Cells, Yeast & Fungi, Insect Cells, Others), by End-users (Biopharmaceutical and Biotechnology Companies, CROs, Academic & Research Institutes, Diagnostic Laboratories, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis

調査会社visiongain社が発行したリサーチレポート（データ管理コード：VGA23MA026）■ 発行会社/調査会社：visiongain
■ 商品コード：VGA23MA026
■ 発行日：2023年4月20日
■ 調査対象地域：グローバル
■ 産業分野：バイオ
■ ページ数：353
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Sigle User（1名様閲覧用、1年間、印刷不可）GBP3,950 ⇒換算￥750,500見積依頼/購入/質問フォーム
Enterprise（法人閲覧用、1年間、印刷可）GBP6,950 ⇒換算￥1,320,500見積依頼/購入/質問フォーム
※visiongain社発行の調査レポートは、Single UserとDept Licence(Five User)の場合、DRM（デジタル著作権管理）付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。

※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※visiongain社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[組換えタンパク質のグローバル市場2023-2033：サイトカイン・成長因子、抗体、酵素、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Visiongain社の本調査資料によると、世界の組換えタンパク質市場規模が、2033年まで年平均11.1%で拡大すると見込まれています。本資料は、組換えタンパク質の世界市場について調査し、市場状況や動向を整理したレポートです。レポート概要、エグゼクティブサマリー、市場動向、製品・サービス別（製品、サービス）分析、用途別（生物製剤生産、創薬・開発、研究、診断、その他）分析、宿主細胞別（哺乳類系、細菌細胞、酵母・菌類、昆虫細胞、その他）分析、エンドユーザー別（バイオ医薬品・バイオテクノロジー企業、CRO、学術・研究機関、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ、アメリカ、カナダ、ドイツ、イギリス、フランス、イタリア、スペイン、ロシア、日本、中国、インド、オーストラリア、韓国、ブラジル、メキシコ、アルゼンチン、中東、南アフリカ、その他地域）分析、企業情報などの項目をまとめています。また、主要な参入企業として、Abcam Plc 、Abnova Corporation 、Avantor Inc.、Bio-Rad Laboratories, Inc. 、Bio-Techne 、Enzo Biochem Inc.、GenScript 、Merck KGaA、PerkinElmer, Inc. 、Proteintech Group, Inc.、RayBiotech Life, Incなどの情報を含んでいます。
・レポート概要
・エグゼクティブサマリー
・市場動向
・世界の組換えタンパク質市場規模：製品・サービス別
- 製品の市場規模
- サービスの市場規模
・世界の組換えタンパク質市場規模：用途別
- 生物製剤生産における市場規模
- 創薬・開発における市場規模
- 研究における市場規模
- 診断における市場規模
- その他用途における市場規模
・世界の組換えタンパク質市場規模：宿主細胞別
- 哺乳類系細胞における市場規模
- 細菌細胞における市場規模
- 酵母・菌類における市場規模
- 昆虫細胞における市場規模
- その他細胞における市場規模
・世界の組換えタンパク質市場規模：エンドユーザー別
- バイオ医薬品・バイオテクノロジー企業における市場規模
- CROにおける市場規模
- 学術・研究機関における市場規模
- その他エンドユーザーにおける市場規模
・世界の組換えタンパク質市場規模：地域別　
- 北米の組換えタンパク質市場規模
アメリカの組換えタンパク質市場規模
カナダの組換えタンパク質市場規模
- ヨーロッパの組換えタンパク質市場規模
ドイツの組換えタンパク質市場規模
イギリスの組換えタンパク質市場規模
フランスの組換えタンパク質市場規模
イタリアの組換えタンパク質市場規模
スペインの組換えタンパク質市場規模
ロシアの組換えタンパク質市場規模
- アジア太平洋の組換えタンパク質市場規模
日本の組換えタンパク質市場規模
中国の組換えタンパク質市場規模
インドの組換えタンパク質市場規模
オーストラリアの組換えタンパク質市場規模
韓国の組換えタンパク質市場規模
- 中南米の組換えタンパク質市場規模
ブラジルの組換えタンパク質市場規模
メキシコの組換えタンパク質市場規模
アルゼンチンの組換えタンパク質市場規模
- 中東・アフリカの組換えタンパク質市場規模
中東の組換えタンパク質市場規模
南アフリカの組換えタンパク質市場規模
- その他地域の組換えタンパク質市場規模
・企業情報

The Recombinant Proteins Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

The rising prevalence and incidence of chronic illnesses, technological innovation, and expanding R&D investments by key companies are the primary drivers driving the growth of the recombinant proteins market. Increased awareness of chronic illnesses among the general public and governments is predicted to improve the market for recombinant goods. According to the World Health Organisation (WHO), chronic illnesses are the leading cause of mortality worldwide, accounting for over 60% of all fatalities.

The increased frequency of chronic illnesses is one of the major factors impacting the market. Diabetes, cancer, respiratory disorders, and cardiovascular disease are only a handful of the most common chronic diseases. According to Globocan forecasts, the number of cancer cases would rise from 19.3 million in 2020 to 24.6 million in 2030. Furthermore, by 2030, there will be 587 million diabetics globally. Chronic illnesses account for over 80% of mortality in middle- and low-income countries. Chronic illnesses are expected to affect more than 49% of the population in the U.S. by 2025. Strokes and heart problems account for 30% of all fatalities in the U.S.

What Questions Should You Ask before Buying a Market Research Report?
• How is the recombinant proteins market evolving?
• What is driving and restraining the recombinant proteins market?
• How will each recombinant proteins submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each recombinant proteins submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading recombinant proteins markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the recombinant proteins projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of recombinant proteins projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the recombinant proteins market?
• Where is the recombinant proteins market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the recombinant proteins market today, and over the next 10 years:
• Our 353-page report provides 146 tables and 248 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the recombinant proteins market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising recombinant proteins prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Product & Services Outlook
• Products
– Cytokines & Growth Factors: Interferons (IFNs), Interleukins (ILs), Others
– Antibodies
– Enzymes: Kinases Enzymes, Metabolic Enzymes, Others
– Recombinant Regulatory Protein
– Hormones
– Virus Antigens
– Immune Checkpoint Proteins
– Others
• Services

Application Outlook
• Biopharmaceutical Production
– Biologics
– Vaccines
– Cell & Gene Therapies
– Others
• Drug Discovery & Development
• Research
• Diagnostics
• Others

Host Cell Outlook
• Mammalian Systems
• Bacterial Cells
• Yeast & Fungi
• Insect Cells
• Others

End-user Outlook
• Biopharmaceutical and Biotechnology Companies
• CROs
• Academic & Research Institutes
• Diagnostic Laboratories
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 18 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe

Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Argentina
• Rest of Latin America

MEA
• GCC
• South Africa
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Recombinant Proteins Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• Abcam Plc
• Abnova Corporation
• Avantor Inc.
• Bio-Rad Laboratories, Inc.
• Bio-Techne
• Enzo Biochem Inc.
• GenScript
• Merck KGaA
• PerkinElmer, Inc.
• Proteintech Group, Inc.
• RayBiotech Life, Inc.
• Sino Biological Inc.
• STEMCELL Technologies
• Thermo Fisher Scientific Inc.

Overall world revenue for Recombinant Proteins Market, 2023 to 2033 in terms of value the market will surpass US$3,079.9 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Recombinant Proteins Market, 2023 to 2033 report help you?
In summary, our 350+ page report provides you with the following knowledge:

• Revenue forecasts to 2033 for Recombinant Proteins Market, 2023 to 2033 Market, with forecasts for product & services, application, host cell, end-user, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2033 for five regional and 22 key national markets – See forecasts for the Recombinant Proteins Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for 14 of the major companies involved in the Recombinant Proteins Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Recombinant Proteins Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Recombinant Proteins Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Rising Demand for Recombinant Products
3.2.1.2 High Funding for Biomedical Research
3.2.1.3 Increase in Number of Elderly Population will Drive the Market Growth
3.2.1.4 Patent Expiration for Biologics
3.2.2 Market Restraining Factors
3.2.2.1 Price Erosion of Recombinant Proteins
3.2.2.2 Stringent Regulation for Recombinant Proteins Production
3.2.3 Market Opportunities
3.2.3.1 Emerging Economies Expansion and Prioritisation of R&D
3.2.3.2 Growing Significance of Genomics and Proteomics
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
3.5.1 Political Factors Impacting Recombinant Proteins Market
3.5.2 Economic Factors Impacting Recombinant Proteins Market
3.5.3 Social Factors Impacting Recombinant Proteins Market
3.5.4 Technological Factors Impacting Recombinant Proteins Market

4 Recombinant Proteins Market Analysis by Product & Services
4.1 Key Findings
4.2 Product & Services Segment: Market Attractiveness Index
4.3 Recombinant Proteins Market Size Estimation and Forecast by Product & Services
4.4 Products
4.4.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.4.3 Cytokines & Growth Factors
4.4.3.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
4.4.3.2 Market Share by Region, 2023 & 2033 (%)
4.4.3.3 Interferons (IFNs)
4.4.3.4 Interleukins (ILs)
4.4.3.5 Others
4.4.4 Antibodies
4.4.4.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
4.4.4.2 Market Share by Region, 2023 & 2033 (%)
4.4.5 Enzymes
4.4.5.1 Enzymes Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
4.4.5.2 Market Share by Region, 2023 & 2033 (%)
4.4.5.3 Kinases enzymes
4.4.5.4 Metabolic enzymes
4.4.5.5 Other Enzymes
4.4.6 Recombinant Regulatory Protein
4.4.6.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
4.4.6.2 Market Share by Region, 2023 & 2033 (%)
4.4.7 Hormones
4.4.7.1 Hormones Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
4.4.7.2 Market Share by Region, 2023 & 2033 (%)
4.4.8 Virus Antigens
4.4.8.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
4.4.8.2 Market Share by Region, 2023 & 2033 (%)
4.4.9 Immune Checkpoint Proteins
4.4.9.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
4.4.9.2 Market Share by Region, 2023 & 2033 (%)
4.4.10 Others
4.4.10.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
4.4.10.2 Market Share by Region, 2023 & 2033 (%)
4.5 Services
4.5.1 Service Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
4.5.2 Market Share by Region, 2023 & 2033 (%)

5 Recombinant Proteins Market Analysis by Application
5.1 Key Findings
5.2 Application Segment: Market Attractiveness Index
5.3 Recombinant Proteins Market Size Estimation and Forecast by Application
5.4 Biopharmaceutical Production
5.4.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.4.3 Biologics
5.4.3.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
5.4.3.2 Market Share by Region, 2023 & 2033 (%)
5.4.4 Vaccines
5.4.4.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
5.4.4.2 Market Share by Region, 2023 & 2033 (%)
5.4.5 Cell & Gene Therapy
5.4.5.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
5.4.5.2 Market Share by Region, 2023 & 2033 (%)
5.4.6 Others
5.4.6.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
5.4.6.2 Market Share by Region, 2023 & 2033 (%)
5.5 Drug Discovery & Development
5.5.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Research
5.6.1 Research Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
5.6.2 Market Share by Region, 2023 & 2033 (%)
5.7 Diagnostics
5.7.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
5.7.2 Market Share by Region, 2023 & 2033 (%)
5.8 Others
5.8.1 Others Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
5.8.2 Market Share by Region, 2023 & 2033 (%)

6 Recombinant Proteins Market Analysis by Host Cell
6.1 Key Findings
6.2 Host Cell Segment: Market Attractiveness Index
6.3 Recombinant Proteins Market Size Estimation and Forecast by Host Cell
6.4 Mammalian Systems
6.4.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 Bacterial Cells
6.5.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
6.5.2 Market Share by Region, 2023 & 2033 (%)
6.6 Yeast & Fungi
6.6.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
6.6.2 Market Share by Region, 2023 & 2033 (%)
6.7 Insect Cells
6.7.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
6.7.2 Market Share by Region, 2023 & 2033 (%)
6.8 Others
6.8.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
6.8.2 Market Share by Region, 2023 & 2033 (%)

7 Recombinant Proteins Market Analysis by End-User
7.1 Key Findings
7.2 Recombinant Proteins Market Size Estimation and Forecast by End-User
7.3 Biopharmaceutical and Biotechnology Companies
7.3.1 Biopharmaceutical and Biotechnology Companies Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
7.3.2 Market Share by Region, 2023 & 2033 (%)
7.4 CROs
7.4.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
7.4.2 Market Share by Region, 2023 & 2033 (%)
7.5 Academic & Research Institutes
7.5.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
7.5.2 Market Share by Region, 2023 & 2033 (%)
7.6 Diagnostic Laboratories
7.6.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
7.6.2 Market Share by Region, 2023 & 2033 (%)
7.7 Others
7.7.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
7.7.2 Market Share by Region, 2023 & 2033 (%)

8 Recombinant Proteins Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast

9 North America Recombinant Proteins Market Analysis
9.1 Key Findings
9.2 North America Recombinant Proteins Market Attractiveness Index
9.3 North America Recombinant Proteins Market by Country, 2023, 2028 & 2033 (US$ Mn)
9.4 North America Recombinant Proteins Market Size Estimation and Forecast by Country
9.5 North America Recombinant Proteins Market Size Estimation and Forecast by Product &Services
9.6 North America Recombinant Proteins Market Size Estimation and Forecast by Product Type
9.7 North America Recombinant Proteins Market Size Estimation and Forecast by Cytokines & Growth Factors Type
9.8 North America Recombinant Proteins Market Size Estimation and Forecast by Enzymes Type
9.9 North America Recombinant Proteins Market Size Estimation and Forecast by Application
9.10 North America Recombinant Proteins Market Size Estimation and Forecast by Biopharmaceuticals Production Type
9.11 North America Recombinant Proteins Market Size Estimation and Forecast by End-User
9.12 North America Recombinant Proteins Market Size Estimation and Forecast by Host Cell
9.13 U.S. Recombinant Proteins Market Analysis
9.14 Canada Recombinant Proteins Market Analysis

10 Europe Recombinant Proteins Market Analysis
10.1 Key Findings
10.2 Europe Recombinant Proteins Market Attractiveness Index
10.3 Europe Recombinant Proteins Market by Country, 2023, 2028 & 2033 (US$ Mn)
10.4 Europe Recombinant Proteins Market Size Estimation and Forecast by Country
10.5 Europe Recombinant Proteins Market Size Estimation and Forecast by Product & Services
10.6 Europe Recombinant Proteins Market Size Estimation and Forecast by Product Type
10.7 Europe Recombinant Proteins Market Size Estimation and Forecast by Cytokines & Growth Factors Type
10.8 Europe Recombinant Proteins Market Size Estimation and Forecast by Enzymes Type
10.9 Europe Recombinant Proteins Market Size Estimation and Forecast by Application
10.10 Europe Recombinant Proteins Market Size Estimation and Forecast by Biopharmaceuticals Production Type
10.11 Europe Recombinant Proteins Market Size Estimation and Forecast by End-User
10.12 Europe Recombinant Proteins Market Size Estimation and Forecast by Host Cell
10.13 Germany Recombinant Proteins Market Analysis
10.14 UK Recombinant Proteins Market Analysis
10.15 France Recombinant Proteins Market Analysis
10.16 Italy Recombinant Proteins Market Analysis
10.17 Spain Recombinant Proteins Market Analysis
10.18 Russia Recombinant Proteins Market Analysis
10.19 Rest of Europe Recombinant Proteins Market Analysis

11 Asia Pacific Recombinant Proteins Market Analysis
11.1 Key Findings
11.2 Asia Pacific Recombinant Proteins Market Attractiveness Index
11.3 Asia Pacific Recombinant Proteins Market by Country, 2023, 2028 & 2033 (US$ Mn)
11.4 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by Country
11.5 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by Product & services
11.6 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by Product Type
11.7 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by Cytokines & Growth Factors Type
11.8 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by Enzymes Type
11.9 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by Application
11.10 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by Biopharmaceuticals Production Type
11.11 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by Host Cell
11.12 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by End-User
11.13 Japan Recombinant Proteins Market Analysis
11.14 China Recombinant Proteins Market Analysis
11.15 India Recombinant Proteins Market Analysis
11.16 Australia Recombinant Proteins Market Analysis
11.17 South Korea Recombinant Proteins Market Analysis
11.18 Rest of Asia Pacific Recombinant Proteins Market Analysis

12 Latin America Recombinant Proteins Market Analysis
12.1 Key Findings
12.2 Latin America Recombinant Proteins Market Attractiveness Index
12.3 Latin America Recombinant Proteins Market by Country, 2023, 2028 & 2033 (US$ Mn)
12.4 Latin America Recombinant Proteins Market Size Estimation and Forecast by Product & Services
12.5 Latin America Recombinant Proteins Market Size Estimation and Forecast by Product Type
12.6 Latin America Recombinant Proteins Market Size Estimation and Forecast by Cytokines & Growth Factors Type
12.7 Latin America Recombinant Proteins Market Size Estimation and Forecast by Enzymes Type
12.8 Latin America Recombinant Proteins Market Size Estimation and Forecast by Application
12.9 Latin America Recombinant Proteins Market Size Estimation and Forecast by Biopharmaceuticals Production Type
12.10 Latin America Recombinant Proteins Market Size Estimation and Forecast by End-User
12.11 Latin America Recombinant Proteins Market Size Estimation and Forecast by Host Cell
12.12 Brazil Recombinant Proteins Market Analysis
12.13 Mexico Recombinant Proteins Market Analysis
12.14 Argentina Recombinant Proteins Market Analysis
12.15 Rest of Latin America Recombinant Proteins Market Analysis

13 MEA Recombinant Proteins Market Analysis
13.1 Key Findings
13.2 MEA Recombinant Proteins Market Attractiveness Index
13.3 MEA Recombinant Proteins Market by Country, 2023, 2028 & 2033 (US$ Mn)
13.4 MEA Recombinant Proteins Market Size Estimation and Forecast by Country
13.5 MEA Recombinant Proteins Market Size Estimation and Forecast by Product & Services
13.6 MEA Recombinant Proteins Market Size Estimation and Forecast by Product Type
13.7 MEA Recombinant Proteins Market Size Estimation and Forecast by Cytokines & Growth Factors Type
13.8 MEA Recombinant Proteins Market Size Estimation and Forecast by Enzymes Type
13.9 MEA Recombinant Proteins Market Size Estimation and Forecast by Application
13.10 MEA Recombinant Proteins Market Size Estimation and Forecast by Biopharmaceuticals Production Type
13.11 MEA Recombinant Proteins Market Size Estimation and Forecast by End-users
13.12 MEA Recombinant Proteins Market Size Estimation and Forecast by End-users
13.13 GCC Recombinant Proteins Market Analysis
13.14 South Africa Recombinant Proteins Market Analysis
13.15 Rest of MEA Recombinant Proteins Market Analysis

14 Company Profiles
14.1 Competitive Landscape, 2022
14.2 Abcam plc
14.2.1 Company Snapshot
14.2.2 Company Overview
14.2.3 Financial Analysis
14.2.3.1 Net Revenue, 2017-2022
14.2.3.2 Regional Market Shares, 2022
14.2.4 Product Benchmarking
14.2.5 Strategic Outlook
14.3 Bio-Techne
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.3.1 Net Revenue, 2017-2022
14.3.3.2 Research & Development, 2017-2022
14.3.3.3 Regional Market Shares, 2022
14.3.3.4 Segmental Market Shares, 2022
14.3.4 Product Benchmarking
14.3.5 Strategic Outlook
14.4 GenScript
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.3.1 Net Revenue, 2017-2022
14.4.3.2 Regional Market Shares, 2022
14.4.3.3 Segmental Market Shares, 2021
14.4.4 Product Benchmarking
14.5 Bio-Rad Laboratories, Inc.
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.3.1 Net Revenue, 2017-2022
14.5.3.2 Regional Market Shares, 2022
14.5.3.3 Segmental Market Shares, 2022
14.5.4 Product Benchmarking
14.5.5 Strategic Outlook
14.6 Merck KGaA
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.3.1 Net Revenue, 2017-2022
14.6.3.2 Research & Development, 2017-2022
14.6.3.3 Regional Market Shares, 2022
14.6.3.4 Segmental Market Shares, 2022
14.6.4 Product Benchmarking
14.7 Thermo Fisher Scientific
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.3.1 Net Revenue, 2017-2022
14.7.3.2 Research and Development, 2017-2022
14.7.3.3 Regional Market Shares, 2022
14.7.3.4 Segmental Market Shares, 2022
14.7.4 Product Benchmarking
14.7.5 Strategic Outlook
14.8 Enzo Biochem Inc.
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.3.1 Net Revenue, 2017-2022
14.8.3.2 Research & Development, 2017-2022
14.8.3.3 Regional Market Shares, 2022
14.8.3.4 Segmental Market Shares, 2022
14.8.4 Product Benchmarking
14.9 Sino Biological, Inc.
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Product Benchmarking
14.10 Proteintech Group, Inc
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Product Benchmarking
14.11 Abnova Corporation
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Product Benchmarking
14.12 RayBiotech Life, Inc.
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Product Benchmarking
14.13 STEMCELL Technologies
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Product Benchmarking
14.14 PerkinElmer Inc.
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Financial Analysis
14.14.3.1 Net Revenue, 2017-2022
14.14.3.2 Research & Development, 2017-2022
14.14.3.3 Regional Market Shares, 2022
14.14.3.4 Segmental Market Shares, 2022
14.14.4 Product Benchmarking
14.14.5 Strategic Outlook
14.15 Avantor Inc.
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Financial Analysis
14.15.3.1 Net Revenue, 2017-2022
14.15.3.2 Regional Market Shares, 2022
14.15.4 Product Benchmarking
14.15.5 Strategic Outlook

15 Conclusion and Recommendations
15.1 Concluding Remarks from
15.2 Recommendations for Market Players



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 研究用タンパク質のグローバル市場（2023～2030）：サイトカイン・成長因子、抗体
  • 組換えタンパク質のグローバル市場予測（～2028）：成長因子、ケモカイン、構造タンパク質、膜タンパク質
  • 組換えタンパク質のグローバル市場2023～2027：バイオテクノロジー研究、創薬・医薬品開発、バイオ医薬品の生産、その他
  • 神経免疫治療薬のグローバル市場（～2030年）：モノクローナル抗体、低分子、組換えタンパク質、サイトカイン、リンパ球、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(VGA23MA026 )"組換えタンパク質のグローバル市場2023-2033：サイトカイン・成長因子、抗体、酵素、その他" (英文：Recombinant Proteins Market Report 2023-2033 : Forecasts by Products & Services (Cytokines & Growth Factors (Interferons (IFNs), Interleukins (ILS), Others), Antibodies, Enzymes (Kinases Enzymes, Metabolic Enzymes, Others), Recombinant Regulatory Protein, Hormones, Virus Antigens, Immune Checkpoint Proteins, Others)), Services), by Application (Biopharmaceutical Production (Biologics, Vaccines, Cell & Gene Therapy, Others), Drug Discovery & Development, Research, Diagnostics, Others)), by Host Cell (Mammalian Systems, Bacterial Cells, Yeast & Fungi, Insect Cells, Others), by End-users (Biopharmaceutical and Biotechnology Companies, CROs, Academic & Research Institutes, Diagnostic Laboratories, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis)はvisiongain社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。